Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 12 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
111 33.0 months Metastatic renal cell carcinoma 4 Immunotherapy
Université de Lyon, Centre Léon Bérard, Medical Oncology Department, Institut National de la Sante et de la Recherche Medicale France 9/2008
Treatment Details: Patients: This study involved 155 patients with metastatic renal cell (kidney) cancer. The median age was 55, ranging from 25 to 74 years old. The majority of patients were men (82%).
 
112 33.0 months Metastatic breast cancer 4 Chemotherapy
Albany Medical Center United States 3/2012
Treatment Details: Patients: This phase 2 study involved women with metastatic breast cancer who were divided into two different patient groups. Group A included 46 patients who had been previously treated w
 
113 33.0 months Malignant pleural mesothelioma 4 Radiation
Surgery
Centro di Riferimento Oncologico of Aviano Italy 1/2014
Treatment Details: Patients: This study involved 20 malignant pleural mesothelioma patients with a median age of 68 years, 18 of whom were male. Treatment: Patients were treated with surgery (radical pleu
 
114 33.0 months NSCLC 4 Chemotherapy
Radiation
Third Affiliated Hospital of Harbin Medical University China 1/2015
Treatment Details: Patients: This study involved non-small cell lung cancer patients who were divided into two separate treatment groups. Group A had 20 patients with an average age of 59.6 years; 75% were m
 
115 32.9 months Advanced Ovarian Cancer 5 Chemotherapy
Surgery
Papa Giovanni XXIII Hospital Italy 1/2015
Treatment Details: Patients: This study involved 54 advanced epithelial ovarian cancer patients with an average age of 54.51 years. Treatment: Patients received surgery and chemotherapy with cisplatin and
 
116 32.8 months Metastatic breast cancer 4 Biologic therapy
Chemotherapy
National Cancer Research Institute Italy 5/2009
Treatment Details: Patients: This phase 2 study involved 45 women with HER-2 positive metastatic breast cancer. Their median age was 55, ranging from 34 to 71 years of age. About half had received radiation
 
117 32.7 months Inoperable hepatocellular carcinoma 1 Radiation
All India Institute of Medical Sciences India 5/2007
Treatment Details: Patients: This clinical trial involved 93 patients (80 men and 13 women) with inoperable liver cancer (hepatocellular carcinoma). The average age was 53 years, ranging from 31 to 76.
 
118 32.4 months Advanced Ovarian cancer 4 Chemotherapy
Institut Paoli-Calmettes France 3/2006
Treatment Details: Patients: This phase II study involved a total of 105 patients and 98 who were eligible for a response with advanced pretreated platinum-sensitive ovarian cancer. The median age was 58.
 
119 32.4 months locally advanced or metastatic breast cancer 4 Chemotherapy
Veterans General Hospital Taiwan Region 3/2005
Treatment Details: Patients: This study involved 29 women with advanced, metastatic, or recurrent breast cancer. The median age was 55 years. All but nine patients had developed an additional metastatic site
 
120 32.4 months Metastatic breast cancer 4 Biologic therapy
Chemotherapy
The West Clinic United States 6/2014
Treatment Details: Patients: This phase 2 study involved female metastatic breast cancer patients who were divided into two separate groups based on treatment and genetic status of their cancer. Group A cons
 
Page 12 of 187  | Previous Page  | Next Page